ARCHIVES

Biotheraputices To Reveal Plans for Expansion

This article is from The Cancer Letter archive.

Vol. 12 No. 32 | August 8, 1986

Download PDF Visit The Full Archive

Related Articles

Mouse Strains Now Available From NCI

March 18, 1983

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

March 13, 1987

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974